XLO XILIO THERAPEUTICS INC Delisting Actions 8-K Filing 2025 - Nasdaq Notice On April 4, 2025, Xilio Therapeutics received a notice from Nasdaq stating that its stock price has been below $1.00 for 30 consecutive business days, which could lead to delisting unless compliance is regained by October 1, 2025.Get access to all SEC 8-K filings of the XILIO THERAPEUTICS INC